nova Session "Potential of Gene Editing & CRISPR/Cas9 for the Bio-based Economy"

CRISPR/Cas9: Huge innovation with almost infinite possibilities or just another dead end of GMO?

 

6 March 2018, 10:00 - 16:30 h
Terminal 1, Airport Cologne/Bonn, Germany


What do modern biotechnology and especially gene editing via CRISPR/Cas9 and similar technologies mean for the bio-based economy? What do these new concepts mean in terms of technology, politics and public perception?

This nova-Session will discuss a demarcation between the controversial GMO discussion and a more holistic and constructive view on gene editing technologies, will highlight the technological possibilities already existing today and will dare a glimpse into what comes next. How mature are the technologies in question and to what extent have they already been regulated? And above all: Which opportunities do they bring now and for the future? What quantum leaps are to be expected from these new technologies of gene editing?

The session will host European top experts with extensive experience in the practical application of gene editing and CRISPR/Cas9 technologies in bacteria, yeasts and plants. Find out first-hand what significance these technologies will have for bio-based chemicals and other areas of the bio-based economy. Discuss with top experts, ask all possible questions about the topic – and get answers.

The number of participants for this exclusive event is limited, please register soon!

Participants are welcome to submit their specific topics of interest beforehand or put them up for discussion at the session.